Seán Kinsella: Mirai Medical is presenting a new technology to the US Oncology Community
Seán Kinsella, Chief Technology Officer at Mirai Medical, posted on LinkedIn:
“Seeing our technology now successfully treating GI cancer patients across Europe, Australia and the UK has been the highlight of my career.
The precision and tissue selectivity of our platform represents years of R and D effort, and I’m looking forward to demonstrating these capabilities live at the conference alongside our clinical specialists.
Toufic Kachaamy and the City of Hope team have been tremendous in providing this opportunity to share our vision for transforming the GI treatment paradigm with the US oncology community.
If you’re attending, please stop by our demonstration or find me throughout the weekend – I’d love to discuss both the technical and clinical aspects of our work.”
Toufic Kachaamy, Chief of Medicine and Director of Gastroenterology at City of Hope, shared this post on LinkedIn, adding:
“I am very excited to have you Seán Kinsella and Mirai Medical showcasing your cancer ablation product to our multidisciplinary audience.
We are also very excited for you to also bring your product to the US market.
Innovation takes all stakeholders to work together for the benefit of cancer patients.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023